Provivi
PrivateLast Round
Early Stage
VC
Apr 7, 2026
Total Funding Raised
$194.5M
Momentum Score
50 /100
Company Overview
Provivi is an agricultural biotechnology company that develops insect pheromones to safeguard food supplies while ensuring a non-toxic and sustainable approach to crop protection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Provivi Comps
Public and private peers based on sector, stage, and business model.
Provivi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Apr 7, 2026 | ||||
| VC Round | Aug 19, 2024 | ||||
| VC Round | Feb 24, 2021 | ||||
| Series C Extension | Dec 22, 2020 | ||||
| Debt | Jun 16, 2020 | ||||
Series C | Oct 15, 2019 |
Key People
Founding team and executive leadership
Provivi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xeraya Capital | Series A |
| Kairos Ventures | Series A, Series C, Series C Extension, Series B, VC Round |
| MLS Capital Fund II, L.P. | Series B, Series A |
| Tybourne Capital Management | Series C |
| The Bill & Melinda Gates Foundation Trust | VC Round |
| Aliment Capital | Series C Extension, Series C |
| Lanx Capital | Series C, VC Round, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
$25.5M raised in early stage VC funding.
- Mar 19, 2026
Partnered with The Andermatt Group for IPM solutions.
Provivi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Provivi's valuation, stock price, and market status.
